Tandem Diabetes Takes Aim At Medtronic's Artificial Pancreas

Insulin pump maker Tandem Diabetes Care (NASDAQ: TNDM) has secured an FDA OK that puts it on track to challenge Medtronic (NYSE: MDT) for the lead in the emerging market for closed-loop insulin systems. Is Tandem Diabetes stock a buy? Produced by beta cells in the pancreas, insulin is necessary for removing glucose from the bloodstream so it can be stored in the liver and muscles for energy.Image source: Getty Images.Continue reading

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News